Cargando…

Multiple drugs: Severe acute respiratory syndrome coronavirus 2 reinfection and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642204/ http://dx.doi.org/10.1007/s40278-021-06628-3

Ejemplares similares

Multiple drugs: Severe acute respiratory syndrome coronavirus 2 infection, renal dysfunction and off label use: case report
Publicado: (2020)

Multiple drugs: Prolongation of the clinical course in severe acute respiratory syndrome coronavirus 2 infection and off label use : case report
Publicado: (2020)

Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report
por: Massanella, Marta, et al.
Publicado: (2021)

Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report
por: Bader, Nimrah, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Cases Corroborated by Sequencing
por: Massachi, Jonathan, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report
por: Awada, Hussein, et al.
Publicado: (2021)

Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children
por: Buddingh, Emilie P., et al.
Publicado: (2021)

Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report
por: Muyldermans, Astrid, et al.
Publicado: (2021)

A Case Report: Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus-2 Variant Causing Reinfection
por: Hossain, Mohammad Enayet, et al.
Publicado: (2021)

Multiple drugs: DRESS syndrome and off label use: case report
Publicado: (2021)

Multiple drugs: Acute pancreatitis and off label use: case report
Publicado: (2021)

Multiple drugs: Acute pancreatitis, hypertriglyceridaemia and off-label use in coronavirus disease 2019: 2 case reports
Publicado: (2020)

Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review
por: Tang, Xiujuan, et al.
Publicado: (2021)

Late reinfection with a different severe acute respiratory syndrome coronavirus-2 clade in a patient with refractory arterial hypertension: a case report
por: García-Abellán, Javier, et al.
Publicado: (2021)

Multiple drugs: Severe diarrhoea, off label use and treatment failure: case report
Publicado: (2022)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Multiple drugs: Coronavirus disease-2019, lack of efficacy and off-label treatment: 21 case reports
Publicado: (2021)

Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Multiple drugs interaction: Serotonin syndrome and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: Acute kidney injury and off label use: 3 case reports
Publicado: (2021)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Multiple drugs: No response and off-label use: case report
Publicado: (2021)

Multiple drugs: Infections and off label use: case report
Publicado: (2021)

Multiple drugs: No improvement and off label use: case report
Publicado: (2022)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection
por: Maier, Hannah E, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
por: Bean, David J, et al.
Publicado: (2021)

Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study
por: Turbett, Sarah E, et al.
Publicado: (2022)

Multiple drugs: Inappropriate antidiuretic hormone secretion syndrome and off-label use: case report
Publicado: (2020)

Multiple drugs: Posterior reversible encephalopathy syndrome following off-label use: case report
Publicado: (2020)

Multiple drugs: Off-label use, lack of efficacy and acquired immunosuppression syndrome: case report
Publicado: (2022)

Multiple drugs: Bilateral acute angle closure glaucoma and off label treatment: case report
Publicado: (2022)

Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2020)

Multiple drugs: Lack of efficacy and off-label use: case report
Publicado: (2020)

Multiple drugs: Liver injury and Off-label-use: case report
Publicado: (2020)

Multiple drugs: Hypoglycaemia secondary to off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_25bb7ua8sdg345suq7irvk37op